Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 25, 2024 | Back issues
Courthouse News Service Courthouse News Service

Soccer Analyst Pleads |Guilty to Drug Scheme

NEWARK, N.J. (AP) — A TV analyst for Major League Soccer's Philadelphia Union pleaded guilty Tuesday to receiving nearly $500,000 in kickbacks for filling unneeded prescriptions for himself and recruiting others to the scheme.

Peter Pappas, of Drexel Hill, Pennsylvania, pleaded guilty to conspiracy to commit health fraud in federal court in Newark. The pharmaceutical salesman admitted he was recruited by a marketing company that was paid by pharmacies to refer people whose insurance paid for compounded medication including pain creams, scar creams and vitamins.

Pappas admitted that he recruited others to join the scheme, including people using a health benefit program for service members and their families managed by the U.S. Department of Defense. He admitted that he attempted to recruit beneficiaries from TRICARE because they gave high reimbursements for compounded medication and cream, federal prosecutors said.

Prosecutors said that while he received $481,773 from the marketing company, his employer, TRICARE and other insurance companies lost at least $3.69 million. Pappas faces up to 10 years in prison and a $250,000 fine when he is sentenced on Oct. 25.

The former goalkeeper on the defunct Philadelphia Kixx indoor soccer team has been the Union's TV analyst since 2013. He is a district sales manager for New Jersey-based pharmaceutical company Celgene, according to his LinkedIn page.

On Twitter, he described himself as a "Canadian former soccer pro turned Rx slinger."

Pappas' LinkedIn and Twitter pages were no longer available online late Tuesday afternoon.

Neither the Union, Celgene nor Pappas' attorneys were immediately available for comment.

Copyright 2016 The Associated Press. All rights reserved.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...